Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Kahn

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Health Progress (Saint Louis, Mo.)|June 9, 2011
Mercy adapts services to region's needsJoseph Kahn, Christine Crain
The Physician and Sportsmedicine|December 29, 2017
lettersKenneth Stevens, David E Martin, Carol Dunning, et al.
Statistics in Medicine|January 12, 2018
A nonparametric method to detect increased frequencies of adverse drug reactions over timeGünter Heimann, Rossella Belleli, Jouni Kerman, et al.
The Physician and Sportsmedicine|December 19, 2017
lettersJoseph Kahn, Daniel L Spada, Steve Yates, et al.
Clinical Pharmacology and Therapeutics|November 11, 2021
A New Comprehensive Approach to Assess the Probability of Success of Development Programs Before Pivotal TrialsLisa V Hampson, Björn Holzhauer, Björn Bornkamp, et al.
Pharmaceutical Statistics|December 15, 2021
Improving the assessment of the probability of success in late stage drug developmentLisa V Hampson, Björn Bornkamp, Björn Holzhauer, et al.
Pharmaceutical Statistics|April 4, 2022
Eliciting judgements about dependent quantities of interest: The SHeffield ELicitation Framework extension and copula methods illustrated using an asthma case studyBjörn Holzhauer, Lisa V Hampson, John Paul Gosling, et al.
The Physician and Sportsmedicine|December 20, 2017
lettersEd Sargent, Laurel Felix, Linda Salz, et al.
The Journal of Headache and Pain|October 3, 2018
Early onset of efficacy with erenumab in patients with episodic and chronic migraineTodd Schwedt, Uwe Reuter, Stewart Tepper, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Health Progress (Saint Louis, Mo.)|June 9, 2011
Mercy adapts services to region's needsJoseph Kahn, Christine Crain
The Physician and Sportsmedicine|December 29, 2017
lettersKenneth Stevens, David E Martin, Carol Dunning, et al.
Statistics in Medicine|January 12, 2018
A nonparametric method to detect increased frequencies of adverse drug reactions over timeGünter Heimann, Rossella Belleli, Jouni Kerman, et al.
The Physician and Sportsmedicine|December 19, 2017
lettersJoseph Kahn, Daniel L Spada, Steve Yates, et al.
Clinical Pharmacology and Therapeutics|November 11, 2021
A New Comprehensive Approach to Assess the Probability of Success of Development Programs Before Pivotal TrialsLisa V Hampson, Björn Holzhauer, Björn Bornkamp, et al.
Pharmaceutical Statistics|December 15, 2021
Improving the assessment of the probability of success in late stage drug developmentLisa V Hampson, Björn Bornkamp, Björn Holzhauer, et al.
Pharmaceutical Statistics|April 4, 2022
Eliciting judgements about dependent quantities of interest: The SHeffield ELicitation Framework extension and copula methods illustrated using an asthma case studyBjörn Holzhauer, Lisa V Hampson, John Paul Gosling, et al.
The Physician and Sportsmedicine|December 20, 2017
lettersEd Sargent, Laurel Felix, Linda Salz, et al.
The Journal of Headache and Pain|October 3, 2018
Early onset of efficacy with erenumab in patients with episodic and chronic migraineTodd Schwedt, Uwe Reuter, Stewart Tepper, et al.
Pageof 1